Search results
Novavax (NASDAQ:NVAX) Trading 3.5% Higher
ETF DAILY NEWS· 2 weeks agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report)’s stock price traded up 3.5% during mid-day trading on Friday . The stock traded as high ...
Shah Capital calls for board shake-up at Novavax (NASDAQ:NVAX)
Seeking Alpha· 2 weeks agoShah Capital, a major shareholder in Novavax, urges board shake-up citing underperformance and...
Better Buy: Bluebird Bio Vs. Novavax
Motley Fool via Yahoo Finance· 2 weeks agoBluebird Bio is an innovative company. If it can grab a small slice of its target market with Lyfgenia, its stock price could soar. The case for Novavax...
What's Going On With Novavax Stock Today? - Novavax (NASDAQ:NVAX)
Benzinga· 2 weeks agoWhat Happened: In a new regulatory filing, Shah Capital, which owns 9.3 million shares of Novavax...
Shah Capital proposes new directors for Novavax board By Investing.com
Investing.com· 2 weeks agoShah Capital, holding a 6.7% stake in vaccine developer Novavax Inc. (NASDAQ: NASDAQ:NVAX), today...
Novavax investor Shah Capital pushes for board shakeup
Reuters via Yahoo News· 2 weeks ago(Reuters) -A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been...
Novavax, Inc. (NVAX) vs. Its Peers: A Comparison – News Heater
NewsHeater· 4 days agoThere are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.” The public float ...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 6 days agoThe shares have been volatile in the past, surging on a bit of good news and plummeting on less...
Raleigh hedge fund urges board shakeup at Novavax - Triangle Business Journal
The Business Journals· 2 weeks agoA Raleigh-based hedge fund is pushing for changes at a struggling vaccine developer. The investment...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 2 weeks agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...